Cargando…
A novel rare sugar inhibitor of murine herpes simplex keratitis
PURPOSE: To determine the therapeutic efficacy of a novel rare sugar, L-psicose, for the treatment of HSV-1 induced herpetic stromal keratitis (HSK) in a mouse eye model. METHODS: One rare sugar L-psicose was assayed for HSV-1 inhibition of in vitro virus adsorption. The IC(50) and IC(90) values of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499707/ https://www.ncbi.nlm.nih.gov/pubmed/27262904 http://dx.doi.org/10.1016/j.jphs.2016.05.004 |
_version_ | 1783248514272198656 |
---|---|
author | Muniruzzaman, Syed McIntosh, Megan Hossain, Ahamed Izumori, Ken Bhattacharjee, Partha S. |
author_facet | Muniruzzaman, Syed McIntosh, Megan Hossain, Ahamed Izumori, Ken Bhattacharjee, Partha S. |
author_sort | Muniruzzaman, Syed |
collection | PubMed |
description | PURPOSE: To determine the therapeutic efficacy of a novel rare sugar, L-psicose, for the treatment of HSV-1 induced herpetic stromal keratitis (HSK) in a mouse eye model. METHODS: One rare sugar L-psicose was assayed for HSV-1 inhibition of in vitro virus adsorption. The IC(50) and IC(90) values of L-psicose were determined using plaque reduction assay (PRA) in CV-1 cell. Female Balb/c mice were corneally infected with HSV-1, strain KOS-GFP; A topical eye drop treatment of L-psicose was started 24 h after infection and continued four times daily for ten consecutive days. The severity of HSK was monitored by slit lamp examination in a masked fashion and Infectious HSV-1 shedding was determined by PRA. RESULTS: L-psicose was found to have anti-viral activity in vitro at an IC(50) dose of 99.5 mM and an IC(90) dose of 160 mM. Topical eye drop treatment with 200 mM L-psicose in PBS solution significantly reduced the severity of HSK compared to the mock treatment group. The in vivo mouse ocular model results of L-psicose therapy correlated with accelerated clearance of virus from eye swabs. CONCLUSION: The results suggest that topical treatment with rare sugar L-psicose has efficacy against HSK through inhibition of HSV-1. |
format | Online Article Text |
id | pubmed-5499707 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
record_format | MEDLINE/PubMed |
spelling | pubmed-54997072017-07-06 A novel rare sugar inhibitor of murine herpes simplex keratitis Muniruzzaman, Syed McIntosh, Megan Hossain, Ahamed Izumori, Ken Bhattacharjee, Partha S. J Pharmacol Sci Article PURPOSE: To determine the therapeutic efficacy of a novel rare sugar, L-psicose, for the treatment of HSV-1 induced herpetic stromal keratitis (HSK) in a mouse eye model. METHODS: One rare sugar L-psicose was assayed for HSV-1 inhibition of in vitro virus adsorption. The IC(50) and IC(90) values of L-psicose were determined using plaque reduction assay (PRA) in CV-1 cell. Female Balb/c mice were corneally infected with HSV-1, strain KOS-GFP; A topical eye drop treatment of L-psicose was started 24 h after infection and continued four times daily for ten consecutive days. The severity of HSK was monitored by slit lamp examination in a masked fashion and Infectious HSV-1 shedding was determined by PRA. RESULTS: L-psicose was found to have anti-viral activity in vitro at an IC(50) dose of 99.5 mM and an IC(90) dose of 160 mM. Topical eye drop treatment with 200 mM L-psicose in PBS solution significantly reduced the severity of HSK compared to the mock treatment group. The in vivo mouse ocular model results of L-psicose therapy correlated with accelerated clearance of virus from eye swabs. CONCLUSION: The results suggest that topical treatment with rare sugar L-psicose has efficacy against HSK through inhibition of HSV-1. 2016-05-20 2016-06 /pmc/articles/PMC5499707/ /pubmed/27262904 http://dx.doi.org/10.1016/j.jphs.2016.05.004 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Muniruzzaman, Syed McIntosh, Megan Hossain, Ahamed Izumori, Ken Bhattacharjee, Partha S. A novel rare sugar inhibitor of murine herpes simplex keratitis |
title | A novel rare sugar inhibitor of murine herpes simplex keratitis |
title_full | A novel rare sugar inhibitor of murine herpes simplex keratitis |
title_fullStr | A novel rare sugar inhibitor of murine herpes simplex keratitis |
title_full_unstemmed | A novel rare sugar inhibitor of murine herpes simplex keratitis |
title_short | A novel rare sugar inhibitor of murine herpes simplex keratitis |
title_sort | novel rare sugar inhibitor of murine herpes simplex keratitis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499707/ https://www.ncbi.nlm.nih.gov/pubmed/27262904 http://dx.doi.org/10.1016/j.jphs.2016.05.004 |
work_keys_str_mv | AT muniruzzamansyed anovelraresugarinhibitorofmurineherpessimplexkeratitis AT mcintoshmegan anovelraresugarinhibitorofmurineherpessimplexkeratitis AT hossainahamed anovelraresugarinhibitorofmurineherpessimplexkeratitis AT izumoriken anovelraresugarinhibitorofmurineherpessimplexkeratitis AT bhattacharjeeparthas anovelraresugarinhibitorofmurineherpessimplexkeratitis AT muniruzzamansyed novelraresugarinhibitorofmurineherpessimplexkeratitis AT mcintoshmegan novelraresugarinhibitorofmurineherpessimplexkeratitis AT hossainahamed novelraresugarinhibitorofmurineherpessimplexkeratitis AT izumoriken novelraresugarinhibitorofmurineherpessimplexkeratitis AT bhattacharjeeparthas novelraresugarinhibitorofmurineherpessimplexkeratitis |